ALLEGAN, Mich., April 28, 2023 /PRNewswire/ — Padagis today announced the launch of Budesonide 2mg Rectal Foam (generic to UcerisĀ®) with 180-days of Competitive Generic Therapy exclusivity. UcerisĀ® is a prescription corticosteroid medicine used to help get active, mild to moderate…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.